Skip to main content
. 2024 Oct 9;10(21):e38806. doi: 10.1016/j.heliyon.2024.e38806

Table 3.

Pathological results.

No 3D 3D P value
No. of patients 177 147
Malignanta 161(91.0) 124 (84.4) 0.069
Pathological stagea <0.001
pT1a 114 (64.4) 93 (63.3)
pT1b 46 (26.0) 20 (13.6)
pT2 0 (0) 7 (4.8)
pT3
1 (0.8)
6 (4.1)
NR 16 (9.0) 21 (14.3)
Tumor size at final pathologyc (mm) 34.5, 30.0 (25.0; 40.0) 35.4, 32.0 (24.0; 40.0) 0.893
Positive surgical margina 4 (2.3) 2 (1.4) 0.433
Histologya 0.003
Clear cell carcinoma
154 (87.0)
113 (76.9)
Angiomyolipoma 8 (4.5) 11 (7.5)
Papillary 7 (4.0) 6 (4.1)
Oncocytoma 1 (0.6) 7 (4.8)
Cromophobe 0 (0.0) 4 (2.7)
Unclassified 5 (2.8) 0 (0.0)
Other 2 (1.1) 6 (4.1)
ISUP gradea 0.168
1 12 (7.5) 16 (13.1)
2 115 (71.4) 87 (71.3)
3
31 (19.3)
19 (15.6)
4 3 (1.9) 0 (0.0)

ISUP = International Society of Urological Pathology; a = no. (%); c = mean, median (interquartile range).